Rational, biologically based treatment of EGFR -mutant non-small-cell lung cancer

Chih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, Yeun-Chung Chang, Fu-Chang Hu, Meng-Chin Tsai, Kuan-Yu Chen, Zhong-Zhe Lin, Ching-Ju Huang, Chia-Tung Shun, Chin-Lun Huang, James Bean, Ann-Lii Cheng, William Pao, Pan-Chyr Yang, Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy Journal of Clinical Oncology. ,vol. 26, pp. 2745- 2753 ,(2008) , 10.1200/JCO.2007.15.6695

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Shoji Okinaga, Haruto Hirano, Kozo Yoshimori, Toshiyuki Harada, Takashi Ogura, Masahiro Ando, Hitoshi Miyazawa, Tomoaki Tanaka, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa, Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR The New England Journal of Medicine. ,vol. 362, pp. 2380- 2388 ,(2010) , 10.1056/NEJMOA0909530

Eric F. Pettersen, Thomas D. Goddard, Conrad C. Huang, Gregory S. Couch, Daniel M. Greenblatt, Elaine C. Meng, Thomas E. Ferrin, UCSF Chimera--a visualization system for exploratory research and analysis. Journal of Computational Chemistry. ,vol. 25, pp. 1605- 1612 ,(2004) , 10.1002/JCC.20084

Martin L. Sos, Mirjam Koker, Barbara A. Weir, Stefanie Heynck, Rosalia Rabinovsky, Thomas Zander, Jens M. Seeger, Jonathan Weiss, Florian Fischer, Peter Frommolt, Kathrin Michel, Martin Peifer, Craig Mermel, Luc Girard, Michael Peyton, Adi F. Gazdar, John D. Minna, Levi A. Garraway, Hamid Kashkar, William Pao, Matthew Meyerson, Roman K. Thomas, PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR Cancer Research. ,vol. 69, pp. 3256- 3261 ,(2009) , 10.1158/0008-5472.CAN-08-4055

Wenjun Zhou, Dalia Ercan, Liang Chen, Cai-Hong Yun, Danan Li, Marzia Capelletti, Alexis B. Cortot, Lucian Chirieac, Roxana E. Iacob, Robert Padera, John R. Engen, Kwok-Kin Wong, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne, Novel mutant-selective EGFR kinase inhibitors against EGFR T790M Nature. ,vol. 462, pp. 1070- 1074 ,(2009) , 10.1038/NATURE08622

Kim-Son H. Nguyen, Susumu Kobayashi, Daniel B. Costa, Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. Clinical Lung Cancer. ,vol. 10, pp. 281- 289 ,(2009) , 10.3816/CLC.2009.N.039

J MENDELSOHN, J BASELGA, Epidermal Growth Factor Receptor Targeting in Cancer Seminars in Oncology. ,vol. 33, pp. 369- 385 ,(2006) , 10.1053/J.SEMINONCOL.2006.04.003

Atsuko Ogino, Hiroyuki Kitao, Seiki Hirano, Akiko Uchida, Masamichi Ishiai, Toshiyuki Kozuki, Nagio Takigawa, Minoru Takata, Katsuyuki Kiura, Mitsune Tanimoto, Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non-Small Cell Lung Cancer Cell Line Cancer Research. ,vol. 67, pp. 7807- 7814 ,(2007) , 10.1158/0008-5472.CAN-07-0681

Manuel Hidalgo, Lillian L. Siu, John Nemunaitis, Jinee Rizzo, Lisa A. Hammond, Chris Takimoto, S. Gail Eckhardt, Anthony Tolcher, Carolyn D. Britten, Louis Denis, Karen Ferrante, Daniel D. Von Hoff, Sandra Silberman, Eric K. Rowinsky, Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies Journal of Clinical Oncology. ,vol. 19, pp. 3267- 3279 ,(2001) , 10.1200/JCO.2001.19.13.3267

Daniel T. Milton, Gregory J. Riely, William Pao, Vincent A. Miller, Mark G. Kris, Robert T. Heelan, Molecular on/off switch. Journal of Clinical Oncology. ,vol. 24, pp. 4940- 4942 ,(2006) , 10.1200/JCO.2006.06.4410